Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Oral L-arginine supplementation and faecal calprotectin levels in very low birth weight neonates

Abstract

Objective:

The objective of this study is to determine the potential effect of oral L-arginine supplementation on intestinal inflammation in very low birth weight (VLBW) neonates, as estimated by faecal calprotectin levels.

Study Design:

The study enrolled 83 VLBW neonates with birth weight 1500 g and gestational age 34 weeks. In this double-blind study, 40 neonates received daily oral L-arginine supplementation of 1.5 mmol kg−1 per day between the 3rd and 28th day of life, and 43 neonates placebo. Stool samples were collected on days 3, 14 and 28, and calprotectin was measured by enzyme-linked immunosorbent assay.

Result:

Calprotectin values significantly decreased over time in both groups (P=0.032). No difference in faecal calprotectin values was recorded between neonates receiving arginine supplementation and neonates receiving placebo at days 3, 14 and 28.

Conclusion:

Faecal calprotectin values decrease with increasing postnatal age in VLBW infants, but this is not related to arginine supplementation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Dale I, Fagerhol MK, Naesgaard I . Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134: 1–6.

    Article  CAS  Google Scholar 

  2. Carroll D, Corfield A, Spicer R, Cairns P . Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis. Lancet 2003; 361: 310–311.

    Article  CAS  Google Scholar 

  3. Vieten D, Cairns P . The role of calprotectin in the diagnosis of neonatal necrotizing enterocolitis. Ir Med J 2005; 98: 69.

    CAS  PubMed  Google Scholar 

  4. Thuijls G, Derikx JP, van Wijck K, Zimmermann LJ, Degraeuwe PL, Mulder TL et al. Non-invasive markers for early diagnosis and determination of the severity of necrotizing enterocolitis. Ann Surg 2010; 251: 1174–1180.

    Article  Google Scholar 

  5. Srinivasan PS, Brandler MD, D’Souza A . Necrotizing Enterocolitis. Clin Perinatol 2008; 35: 251–272.

    Article  Google Scholar 

  6. de Oliveira ND, Miyoshi MH . Advances in necrotizing enterocolitis. J Pediatr (Rio J) 2005; 81 (1suppl): S16–S22.

    Article  Google Scholar 

  7. MacKendrick W, Caplan M, Hsueh W . Endogenous nitric oxide protects against platelet-activating factor-induced injury in the rat. Pediatr Res 1993; 34: 222–228.

    Article  CAS  Google Scholar 

  8. Cintra AE, Martins JL, Patricio FR, Higa EM, Montero EF . Nitric oxide levels in the intestines of mice submitted to ischemia and reperfusion: L-arginine effects. Transplant Proc 2008; 40: 830–835.

    Article  CAS  Google Scholar 

  9. Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 2009; 37: 153–168.

    Article  CAS  Google Scholar 

  10. Batshaw ML, Wachtel RC, Thomas GH, Starrett A, Brusilow SW . Arginine-responsive asymptomatic hyperammonemia in the premature infant. J Pediatr 1984; 105: 86–91.

    Article  CAS  Google Scholar 

  11. He Q, Kong X, Wu G, Ren P, Tang H, Hao F et al. Metabolomic analysis of the response of growing pigs to dietary L-arginine supplementation. Amino Acids 2009; 37: 199–208.

    Article  CAS  Google Scholar 

  12. Wu G, Jaeger LA, Bazer FW, Rhoads JM . Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem 2004; 15: 442–451.

    Article  CAS  Google Scholar 

  13. Nankervis CA, Giannone PJ, Reber KM . The neonatal intestinal vasculature: contributing factors to necrotizing enterocolitis. Semin Perinatol 2008; 32: 83–91.

    Article  Google Scholar 

  14. Zamora SA, Amin HJ, McMillan DD, Kubes P, Fick GH, Bützner JD et al. Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis. J Pediatr 1997; 131: 226–232.

    Article  CAS  Google Scholar 

  15. Becker RM, Wu G, Galanko JA, Chen W, Maynor AR, Bose CL et al. Reduced serum amino acid concentrations in infants with necrotizing enterocolitis. J Pediatr 2000; 137: 785–793.

    Article  CAS  Google Scholar 

  16. Richir MC, Siroen MP, van Elburg RM, Fetter WP, Quik F, Nijveldt RJ et al. Low plasma concentrations of arginine and asymmetric dimethylarginine in premature infants with necrotizing enterocolitis. Br J Nutr 2007; 97: 906–911.

    Article  CAS  Google Scholar 

  17. Neu J . Arginine supplementation and the prevention of necrotizing enterocolitis in very low birth weight infants. J Pediatr 2002; 140: 389–391.

    Article  Google Scholar 

  18. Amin HJ, Zamora SA, McMillan DD, Fick GH, Butzner JD, Parsons HG et al. Arginine supplementation prevents necrotizing enterocolitis in the premature infant. J Pediatr 2002; 140: 425–431.

    Article  CAS  Google Scholar 

  19. Ballard JL, Novak KK, Driver M . A simplified score for assessment of fetal maturation of newly born infants. J Pediatr 1979; 95 (5 Part 1): 769–774.

    Article  CAS  Google Scholar 

  20. Lemons JA, Reyman D, Moye L . Amino acid composition of preterm and term breast milk during early lactation. Early Hum Dev 1983; 8: 323–329.

    Article  CAS  Google Scholar 

  21. Klein CJ . Nutrient requirements for preterm infant formulas. J Nutr 2002; 132 (6 Suppl 1): 1395S–13577.

    Article  CAS  Google Scholar 

  22. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. Neonatal necrotising enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1–7.

    Article  CAS  Google Scholar 

  23. Neu J . Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention. Pediatr Clin North Am 1996; 43: 409–432.

    Article  CAS  Google Scholar 

  24. Caplan MS, Jilling T . New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001; 13: 111–115.

    Article  CAS  Google Scholar 

  25. Neu J . Arginine supplementation for neonatal necrotizing enterocolitis: are we ready? Br J Nutr 2007; 97: 814–815.

    Article  CAS  Google Scholar 

  26. Batsha ML . Long term treatment of inborn errors of urea synthesis. In: Kleinberger G, Ferenci P, Riederer P, Thaler H (eds). Advances in hepatic encephalopathy and urea cycle disease. Karger: Basel (Switzerland), 1984, pp 187–195.

    Google Scholar 

  27. Urea Cycle Disorders Conference Group. Consensus statement from a conference for the management of patients with urea cycle disorders. J Pediatr 2001; 138 (1 Suppl): S1–S5.

    Google Scholar 

  28. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y . Faecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 2003; 37: 468–472.

    Article  CAS  Google Scholar 

  29. Campeotto F, Butel MJ, Kalach N, Derrieux S, Aubert-Jacquin C, Barbot L et al. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed 2004; 89: F353–F355.

    Article  CAS  Google Scholar 

  30. Campeotto F, Kalach N, Lapillonne A, Butel MJ, Dupont C, Kapel N . Time course of faecal calprotectin in preterm newborns during the first month of life. Acta Paediatr 2007; 96: 1531–1533.

    Article  Google Scholar 

  31. Campeotto F, Baldassarre M, Butel MJ, Viallon V, Nganzali F, Soulaines P et al. Fecal calprotectin: cutoff values for identifying intestinal distress in preterm infants. J Pediatr Gastroenterol Nutr 2009; 48: 507–510.

    CAS  PubMed  Google Scholar 

  32. Nissen AC, van Gils CE, Menheere PP, Van den Neucker AM, van der Hoeven MA, Forget PP . Fecal calprotectin in healthy term and preterm infants. J Pediatr Gastroenterol Nutr 2004; 38: 107–108.

    Article  Google Scholar 

  33. Yang Q, Smith PB, Goldberg RN, Cotten CM . Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life. Neonatology 2008; 94: 267–271.

    Article  CAS  Google Scholar 

  34. Kapel N, Campeotto F, Kalach N, Baldassarre M, Butel MJ, Dupont C . Faecal calprotectin in term and preterm neonates. J Pediatr Gastroenterol Nutr 2010; 51: 542–547.

    Article  CAS  Google Scholar 

  35. Laforgia N, Baldassarre ME, Pontrelli G, Indrio F, Altomare MA, Di Bitonto G . Calprotectin levels in meconium. Acta Paediatr 2003; 92: 463–466.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all the parents for their willingness to participate in this research study and all the nurses of the Neonatal Unit of ‘Alexandra’ Hospital for their help with the study. Further, we acknowledge EM Delicha for statistical analysis and NP Polycarpou for the evaluation of X-rays. This work is registered in ClinicalTrials.gov with Unique Protocol ID: ALEXANDRA 9159.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Polycarpou.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Polycarpou, E., Zachaki, S., Papaevangelou, V. et al. Oral L-arginine supplementation and faecal calprotectin levels in very low birth weight neonates. J Perinatol 33, 141–146 (2013). https://doi.org/10.1038/jp.2012.51

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2012.51

Keywords

This article is cited by

Search

Quick links